A r t i c l e s the synthetic DNA poly(dA:dT) was impaired in cells treated with DDX41-specific shRNA, but induction of IFN-β by the RNA ligand poly(I:C) was not ( Supplementary Fig. 1a,b) , which demonstrated the specificity of DDX41 for c-di-GMP, c-di-AMP and B-DNA. Type I interferons mediate the innate immune response via the receptor for IFN-α/β, whereby ligation of the receptor leads toward the activation of hundreds of interferon-stimulated genes 15 . Both c-di-GMP and c-di-AMP activated the interferon-stimulated gene Mx1 in control cells; however, the induction of Mx1 was much lower in cells treated with DDX41-or STING-specific shRNA (Fig. 1e,f ) . Similarly, the c-di-GMP-mediated activation of other interferon-stimulated genes was also impaired in cells treated with DDX41-specific shRNA ( Supplementary Fig. 1c-f ). These results indicated a critical role for DDX41 in cyclic dinucleotide-mediated activation of type I interferon and interferon-mediated signaling. The cytosolic detection of bacterial secondary messengers also leads to the activation of NF-κB, a key transcription factor important for the induction of proinflammatory cytokines such as interleukin 6 (IL-6) and tumor-necrosis factor 16 . We found that expression of the genes encoding IL-6 and tumor-necrosis factor was much lower in cells treated with DDX41specific shRNA than in cells treated with control shRNA, when the cells were also treated with c-di-GMP and/or c-di-AMP (Fig. 1g,h and Supplementary Fig. 1g ).
To determine whether DDX41 mediates the sensing of c-di-GMP and c-di-AMP and activation of type I interferon in human cells, we stably knocked down DDX41 through the use of shRNA in the human monocyte cell line THP-1 (Fig. 1i) . Consistent with our findings obtained with mouse cells, both c-di-GMP and c-di-AMP induced (e-g) Quantitative PCR analysis of Ddx41 mRNA (e) or Ifnb mRNA (f,g) in primary mouse peritoneal macrophages transfected with control siRNA or siRNA targeting DDX41, then given no further treatment (e) or stimulated for 6 h with L. monocytogenes (f) or c-di-GMP (g); results are presented relative to those of Rpl32 mRNA. (h-j) Quantitative PCR analysis of DDX41 mRNA (h) and IFNB mRNA (i,j) in primary human PBMCs transfected and stimulated as in e (h), f (i) or g (j); results are presented relative to those of mRNA encoding ribosomal protein 36B4). Data are representative of at least two independent experiments (error bars (b-j), s.e.m.). 
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A r t i c l e s the production of IFN-β in THP-1 cells treated with control shRNA, whereas c-di-GMP-or c-di-AMP-mediated production of IFN-β was very defective in THP-1 cells treated with DDX41-or STING-specific shRNA ( Fig. 1j,k) . The induction of interferon-stimulated genes in response to c-di-GMP was also impaired in THP-1 cells treated with DDX41-specific shRNA ( Supplementary Fig. 1h-l) . In addition, the DDX41-STING signaling axis was required for the induction of IFN-β in THP-1 cells stimulated with B-DNA ( Supplementary Fig. 1m ). These results suggested that DDX41 functioned in regulating the induction of genes encoding type I interferons and proinflammatory molecules in response to cyclic dinucleotides in both mouse and human cells.
DDX41 mediates cyclic-dinucleotide sensing in primary cells
We also examined the role of DDX41 in facilitating the activation of type I interferon induced by c-di-GMP or c-di-AMP in primary cells. We prepared BMDCs (mouse DCs derived from bone marrow through the use of granulocyte-macrophage colony-stimulating factor) and transfected the cells with shRNA targeting DDX41 ( Fig. 2a ). BMDCs treated with control shRNA and infected with L. monocytogenes had robust production of IFN-β, much greater than that of BMDCs treated with DDX41-specific shRNA and infected similarly ( Fig. 2b) . Stimulation with c-di-GMP or c-di-AMP also induced the production of IFN-β in BMDCs treated with control shRNA, whereas IFN-β production was considerably impaired in BMDCs treated with DDX41-specific shRNA and stimulated similarly ( Fig. 2c,d) . Similarly, thioglycollate-elicited primary mouse peritoneal macrophages transfected with small interfering RNA (siRNA) targeting DDX41 ( Fig. 2e ) had less activation of IFN-β in response to infection with L. monocytogenes or stimulation with c-di-GMP than did cells transfected with control siRNA and infected or stimulated similarly ( Fig. 2f,g) . Consistent with that, the induction of Mx1 and Il6 was also impaired in peritoneal macrophages transfected with DDX41-specific siRNA and infected with L. monocytogenes or treated with c-di-GMP ( Supplementary Fig. 2a-d) .
To determine whether DDX41 has a role in sensing c-di-GMP in primary human cells, we transfected peripheral blood mononuclear cells (PBMCs) with siRNA specific for DDX41 ( Fig. 2h) . Whereas transfection of PBMCs with control siRNA followed by infection with L. monocytogenes or treatment with c-di-GMP elicited activation of IFN-β, PBMCs transfected with DDX41-specific siRNA showed defective IFN-β activation in response to L. monocytogenes or c-di-GMP ( Fig. 2i,j) . PBMCs obtained from two additional human donors and transfected with DDX41-specific siRNA had similarly lower IFN-β activation ( Supplementary Fig. 2e,f) . These results further indicated a critical role for DDX41 in facilitating type I interferon responses induced by c-di-GMP or c-di-AMP in primary cells of the immune system. 
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A r t i c l e s DDX41 is a direct sensor of c-di-GMP DDX41 is known not only to signal via STING to activate type I interferon but also to function as a PRR that directly binds viral DNA and B-DNA 17 . We therefore investigated whether DDX41 functions as a direct sensor (PRR) for c-di-GMP or c-di-AMP. Biotin-labeled c-di-GMP or c-di-AMP precipitated ectopically expressed DDX41 from lysates of human embryonic kidney 293T cells ( Fig. 3a and Supplementary Fig. 3a ). Immunofluorescence microscopy further showed that DDX41 and c-di-GMP localized together after transfection of D2SC cells with expression vector for DDX41 and with biotinylated c-di-GMP (Fig. 3b) . In addition, we found that DDX41 purified from Escherichia coli through the use of glutathione S-transferase or histidine directly bound c-di-GMP ( Fig. 3c and Supplementary Fig. 3b) .
The interaction of c-di-GMP with DDX41 was specific, as only unlabeled c-di-GMP, c-di-AMP and poly(dA:dT) (B-DNA) competitively disrupted the DDX41-c-di-GMP interaction, but poly(I:C) did not (Fig. 3d) . Furthermore, the structurally similar molecules GMP and AMP also disrupted the DDX41-c-di-GMP complex, but the c-di-GMP and c-di-AMP precursors GTP and ATP, respectively, did not (Supplementary Fig. 3c ).
To determine whether the binding of c-di-GMP was specific to DDX41, we assessed the binding of c-di-GMP to DDX58, another helicase PRR. We found that c-di-GMP bound to DDX41 but showed no interaction with DDX58 ( Supplementary Fig. 3d ). To define which domain of DDX41 was important for the binding of c-di-GMP or c-di-AMP, we used a series of deletion mutants of DDX41 (Fig. 4a,b ) and evaluated their interaction with biotinylated c-di-GMP or c-di-AMP in 293T cells. We found that c-di-GMP and c-di-AMP did not interact with DDX41 lacking the central DEADbox domain (Fig. 4c,d) . To determine the physiological relevance of this domain in terms of the induction of type I interferon, we treated THP-1 cells with DDX41-specific shRNA and reconstituted the cells with either full-length DDX41 or the DDX41 deletion 
A r t i c l e s mutant lacking the DEAD-box domain (Fig. 4e) . As expected, cells treated with DDX41-specific shRNA had less production of IFN-β in response to c-di-GMP or c-di-AMP than did cells treated with control shRNA (Fig. 4f,g) . However, in cells treated with DDX41specific shRNA, reconstitution with full-length DDX41 restored IFN-β production in response to stimulation with c-di-GMP or c-di-AMP, but reconstitution with the DDX41 deletion mutant lacking the DEAD-box domain did not (Fig. 4f,g) . Thus, the cyclic dinucleotide-mediated induction of IFN-β required the central DEAD-box domain of DDX41.
Requirement for DDX41 in cyclic dinucleotide signaling DDX41 interacted with and localized together with STING ( Supplementary Fig. 4a,b) to facilitate DNA ligand-dependent signal transduction 17 . The introduction of either c-di-GMP or c-di-AMP into D2SC cells led to enhanced formation of the DDX41-STING complex (Fig. 5a) . In DNA-dependent signaling pathways, STING further binds to the downstream kinase TBK1 to activate the type I interferon response 18, 19 . When transfected into control D2SC cells, both c-di-GMP and c-di-AMP activated formation of the STING-TBK1 complex; however, c-di-GMP-or c-di-AMP-mediated activation of the STING-TBK1 complex was almost completely abrogated in cells treated with DDX41-specific shRNA (Fig. 5b) . Consequently, c-di-GMP-or c-di-AMP-mediated activation of TBK1, IRF3 and the downstream type I interferon effector STAT1 was impaired in cells treated with DDX41-specific shRNA ( Fig. 5c and Supplementary  Fig. 5 ). Activation of NF-κB was also impaired in cells treated with DDX41-specific shRNA in response to either c-di-GMP or c-di-AMP (Fig. 5c) . Together our findings suggested that DDX41 was a critical PRR for c-di-GMP-and c-di-AMP-mediated induction of interferon and that its absence generated a defect in downstream STINGdependent signaling.
Signaling by c-di-GMP to STING via DDX41
A published study has shown that c-di-GMP binds to the carboxyterminal domain of STING (amino acids 139-379) and suggested that STING might function as an immunological sensor of c-di-GMP 20 .
We therefore used binding assays to determine the affinity of c-di-GMP or c-di-AMP for DDX41 and for STING in parallel. Biotin-labeled c-di-GMP precipitated more ectopically expressed DDX41 than ectopically expressed STING from lysates of 293T cells (Fig. 6a) , indicative of the greater affinity of c-di-GMP for DDX41 than for STING. Physiologically, the binding of c-di-GMP to endogenous DDX41 was also greater than the association of c-di-GMP with endogenous STING (Fig. 6b) . Immunofluorescence imaging further showed more colocalization of c-di-GMP and DDX41 (34.13%) than of c-di-GMP and STING (6.25%; Fig. 6c ). We also used affinity capillary electrophoresis to examine the binding affinity of c-di-GMP for recombinant DDX41 or a recombinant carboxy-terminal domain of STING. We found that c-di-GMP bound DDX41 with a dissociation constant of ~5.65 µM, whereas c-di-GMP associated with the carboxy-terminal domain of STING with a dissociation constant of ~14.54 µM (Fig. 6d) . Consistent with those findings, in precipitation binding assays, c-di-GMP bound with stronger affinity to purified recombinant DDX41 than to the purified recombinant carboxyterminal domain of STING (Fig. 6e) . We therefore hypothesized that DDX41 was the main sensor of c-di-GMP and c-di-AMP and operated upstream of STING, and after binding those pathogenassociated molecular patterns, yielded enhanced complex formation with STING to facilitate downstream signaling and activation of type I interferon (Supplementary Fig. 6 ).
In agreement with those findings, c-di-GMP was considerably impaired in its ability to associate with ectopically expressed STING in 293T cells transfected with siRNA targeting DDX41 (Fig. 7a) . Consistent with that, the localization of c-di-GMP together with STING was much lower in cells treated with DDX41-specific shRNA, whereas DDX41-c-di-GMP interactions remained intact in cells treated with STING-specific shRNA (Fig. 7b,c) . Together, our findings indicated that DDX41 was the main PRR for c-di-GMP and c-di-AMP and signaled via STING for the induction of type I interferon.
DISCUSSION
Many bacterial pathogens, including Staphylococcus, Streptococcus, Pseudomonas, Yersiniae, Listeria and Mycobacteria species, use key secondary messengers such as c-di-GMP or c-di-AMP, which have essential modulatory roles in bacteria 4, 7 . Although several substrates and effectors have been identified for these cyclic dinucleotide monophosphate species in the bacterial cell, understanding of how these bacteriaspecific secondary messengers modulate the innate immune response in the mammalian host cell is just beginning to emerge. Both c-di-GMP and c-di-AMP activate the host type I interferon response in a manner dependent on STING 10, 11 , and our findings have indicated that the DNA sensor and helicase DDX41 functioned as a direct PRR for these cyclic dinucleotides in both mouse and human cells. Our results have shown that unlabeled c-di-GMP or c-di-AMP disrupted the DDX41-c-di-GMP interaction. We found that GMP and AMP also competitively disrupted the DDX41-c-di-GMP complex, but the bulkier GTP or ATP did not. Although two molecules of GMP or of AMP are structurally similar to c-di-GMP or c-di-AMP, respectively, they are not known to function as pathogen-associated molecular patterns in mammalian cells 9 . It will therefore be of further interest to determine how these species serve a modulatory role in the type I interferon response. Our competition experiments additionally showed that B-DNA disrupted the DDX41-c-di-GMP complex. Indeed, DDX41 has been shown to function as a sensor for B-DNA as well 17 . The mechanism by which DDX41 binds B-DNA, as well as cyclic dinucleotides, as demonstrated by co-crystallization studies and point-mutation analysis, requires further investigation.
Our results additionally indicated that the activation of innate signaling and induction of type I interferons mediated by c-di-GMP and c-di-AMP were similarly defective in cells in which DDX41 or STING had been knocked down, which suggested that DDX41 and STING share a common signaling pathway. STING-deficient cells had a very modest defect in the activation of NF-κB in response to c-di-GMP or c-di-AMP. The reason for this phenomenon is not entirely clear 10 ; however, it may be possible that there is redundancy or compensation in signaling to NF-κB. Another DNA sensor, IFI16 (p204), has also been shown to facilitate some viral DNA-triggered signaling via the STING adaptor 21, 22 . Although the possibility of a role for IFI16 in the c-di-GMP and c-di-AMP signaling pathway cannot be ruled out, it is unlikely that IFI16 functions as a chief sensor for these molecules, as its basal expression is low and it is induced in a type I interferon-dependent manner. The expression of DDX41, in contrast, is greater in the basal state and is not modulated by type I interferons 17 .
Our data suggested that DDX41 served as the PRR for c-di-GMP and c-di-AMP, which, after binding to the receptor, signaled to TBK1-IRF3 via STING. Lending further credibility to the proposal that it serves as a scaffolding molecule, STING has been shown to bridge TBK1-IRF3 interactions for optimal signaling 23 . Nevertheless, consistent with a published report 20 , we also found that c-di-GMP associated with STING; however, the interaction of c-di-GMP with DDX41 was much greater. Although the physiological relevance of this interaction requires further investigation, our data have shown that the interaction of c-di-GMP with STING was substantially enhanced in the presence of DDX41 in cells. The solved structure of the carboxy-terminal domain of STING in complex with c-di-GMP has shown that one molecule of c-di-GMP binds one dimer of STING [24] [25] [26] [27] [28] . We propose that the detection of c-di-GMP and its binding to DDX41 promote enhanced DDX41-STING interactions, leading to an increase in the binding affinity of STING for c-di-GMP, which ultimately drives downstream signaling events. Thus, STING may function as a secondary receptor or coactivator in the cyclicdinucleotide signaling pathway.
The importance of the induction of type I interferon in the context of antibacterial innate immunity is unclear and somewhat controversial at present, particularly because of conflicting reports about whether type I interferon functions to support or to inhibit bacterial growth [29] [30] [31] [32] . It will therefore be of interest to further study how various bacteria and host cells use secondary messengers and DDX41 as virulence factors and receptors of the innate immune system, respectively, in their battle of infection and immunity [33] [34] [35] . Thus, cyclicdinucleotide species and DDX41 represent new targets for modulation of their interaction during certain bacterial infections to alter the host immune response to suppress bacterial replication and spread.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary information is available in the online version of the paper.
